The MarketReader Minute
💊 Biotech in Focus Amid Social Buzz and Mixed Stock Moves; Incyte Advances, Sarepta Sinks | Biotech Sector Insights
Biotech remains in the spotlight; Incyte posted early gains on a “Buy” upgrade and new mutCALR therapy data, while Sarepta’s steep drop offset sector momentum. IBB closed unchanged despite broader small-cap strength via the Russell 2000.